Parkinson’s disease patients appear leg walking, drug treatment program needs to be based on the overall condition of the comprehensive development.
Parkinson’s disease is a chronic neurodegenerative disease, once the disease is diagnosed, it is necessary to start drug treatment as early as possible, the principle of its medication emphasizes personalization, the choice of drugs for different patients need to take into account the characteristics of the disease, mainly whether the disease is predominantly tremor or predominantly tonic and hyperkinetic, and also pay attention to a variety of factors such as the severity of the disease, the presence or absence of cognitive impairment, the age of onset, and the side effects of the drug.
Commonly used therapeutic drugs for Parkinson’s disease include anticholinergics such as phenazopyridine, amantadine, compound levodopa, dopamine agonists such as pramipexole, and irreversible inhibitors of selective B-type monoamine oxidase such as silagiline, etc. Specific drug treatment programs need to be formulated by the doctor according to the patient’s condition, and the dosage adjustments should be made gradually in the follow-up visits.
It is recommended to actively seek medical advice and standardize the use of medication under the guidance of the doctor to avoid causing drug tolerance and serious adverse drug reactions and other conditions.